Pindolol (ANI Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the Pindolol drug offered from ANI Pharmaceuticals, Inc.. This Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | ANI Pharmaceuticals, Inc. |
NON-PROPRIETARY NAME: | Pindolol |
SUBSTANCE NAME: | PINDOLOL |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2017-05-08 |
END MARKETING DATE: | 0000-00-00 |
Pindolol HUMAN PRESCRIPTION DRUG Details:
Item Description | Pindolol from ANI Pharmaceuticals, Inc. |
LABELER NAME: | ANI Pharmaceuticals, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 5(mg/1) |
START MARKETING DATE: | 2017-05-08 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 62559-560_1b312ae8-9c0b-40fa-b313-9720d4590748 |
PRODUCT NDC: | 62559-560 |
APPLICATION NUMBER: | ANDA073608 |
Other PINDOLOL Pharmaceutical Manufacturers / Labelers: